<DOC>
	<DOCNO>NCT01581710</DOCNO>
	<brief_summary>Primary hypothesis : Montelukast decrease bronchial hyperresponsiveness subject persistent allergic rhinitis compare treated placebo double- blind , placebo-controlled , cross-over 5-week randomize trial . Secondary hypothesis : There significant correlation allergic rhinitis severity bronchial hyperresponsiveness severity baseline lung function measure . Tertiary hypothesis : Subjects respond well montelukast particular characteristic allergic rhinitis compare respond montelukast .</brief_summary>
	<brief_title>Bronchoprotection Effect Montelukast Children With Persistent Allergic Rhinitis</brief_title>
	<detailed_description>This study randomize , double-blind , placebo-controlled , cross-over , multicenter ( 2 institute ) study washout period least 1 wk study period . Subjects persistent allergic rhinitis , define recommendation Allergic Rhinitis Impact Asthma ( ARIA ) guideline , assessed historical data , recruit . Persistent allergic rhinitis mean symptoms present 4 day week 4 consecutive week . Inclusion criterion persistent rhinitis patient ( preschool child , 3-6 year ) , child old enough cooperate perform pulmonary function testing , child respiratory symptom 4 week prior begin study child without overt asthma chronic respiratory symptom . Exclusion criterion follow : prior document history asthma refer asthma symptom within 1 year , respiratory symptom include cough , wheeze , dyspnea , shortness breath , impaired FEV1 value ( &lt; 80 % predict ) , &lt; 0.75 FEV1/FVC ratio , presence acute chronic upper respiratory infection , anatomical nasal disorder ( ex , nasal polyp , septum deviation , etc . ) , previous current specific immunotherapy , use systemic corticosteroid , admission visit emergency department previous 4 week .</detailed_description>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>child diagnose persistent rhinitis patient base GINA guideline child old enough cooperate perform pulmonary function test legal guardian sufficiently listen purpose voluntarily agree participation sign write consent approve IRB child respiratory symptom 4 week prior begin study child without overt asthma chronic respiratory symptom . prior documented history asthma refer asthma symptom within 1 year respiratory symptom suggestive bronchial asthma , chronic cough , wheeze , dyspnea , shortness breath impair FEV1 value ( &lt; 80 % predict ) , &lt; 0.75 FEV1/FVC ratio presence acute chronic upper respiratory infection , anatomical nasal disorder ( ex , nasal polyp , septum deviation , etc . ) , previous current specific immunotherapy . use systemic corticosteroid past 4 week . admission visit emergency department past 4 week .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>7 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Leukotriene Antagonists</keyword>
	<keyword>Bronchial Hyperreactivity</keyword>
</DOC>